Houston, TX -- (SBWIRE) -- 12/10/2012 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
MELA Sciences, Inc. (NASDAQ:MELA) is trading at $1.72. MELA Sciences, Inc. is a medical device company focused on the commercialization of its product, MelaFind, and the further design and development of MelaFind and its technology. MelaFind is a non-invasive, point-of-care (in the doctor’s office) instrument to aid in the detection of melanoma. MelaFind, features a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions.
Can MELA Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Affymetrix, Inc. (NASDAQ:AFFX) is higher 0.51% and is trading at $3.97. Affymetrix, Inc. (Affymetrix) is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. Affymetrix has developed its GeneChip system and related microarray technology as a platform for acquiring, analyzing and managing genetic information. The Company offers a line of products for two principal applications: genotyping and gene expression.
How Should Investors Trade AFFX After The Recent Volatile Moves? Find Out Here
Amicus Therapeutics, Inc. (NASDAQ:FOLD) fell 1.64% and is trading at $3.60. Amicus Therapeutics, Inc. (Amicus) is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for treating a range of diseases, including lysosomal storage diseases and diseases of neurodegeneration. It is focused on the development of pharmacological chaperone monotherapy programs and pharmacological chaperones in combination with enzyme replacement therapy (ERT).
Is FOLD Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here
Brigus Gold Corp (USA) (NYSE:BRD) is higher 0.18% and is trading at $0.902. Brigus Gold Corp. (Brigus) is a mining company. The Company is engaged in the extraction, processing, and refining of gold deposits, as well as related activities, including the acquisition, exploration and development of mineral properties principally located in North America. Its sole mining operation is the Black Fox Mine.
Can BRD Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
James River Coal Company (NASDAQ:JRCC) is trading at $3.30. James River Coal Company mines engaged in processing and selling of thermal and metallurgical coal through eight active mining complexes located throughout eastern Kentucky, southern West Virginia and southern Indiana. The Company has two business segments based on the coal basins in which it operates: Central Appalachia (CAPP) and the Midwest. As of December 31, 2011, its eight mining complexes included 25 underground mines, 12 surface mines and 14 preparation plants.
Is JRCC Ready To Move Back To New Highs This Year? Find Out Here
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)